75.19
price down icon6.77%   -5.46
after-market アフターアワーズ: 74.70 -0.49 -0.65%
loading
前日終値:
$80.65
開ける:
$79.18
24時間の取引高:
4.07M
Relative Volume:
0.84
時価総額:
$9.80B
収益:
$638.78M
当期純損益:
$-22.66M
株価収益率:
-431.14
EPS:
-0.1744
ネットキャッシュフロー:
$122.18M
1週間 パフォーマンス:
-23.07%
1か月 パフォーマンス:
+9.62%
6か月 パフォーマンス:
+223.12%
1年 パフォーマンス:
+555.54%
1日の値動き範囲:
Value
$71.61
$80.47
1週間の範囲:
Value
$70.94
$102.81
52週間の値動き範囲:
Value
$11.16
$102.81

10 X Genomics Inc Stock (TXG) Company Profile

Name
名前
10 X Genomics Inc
Name
セクター
Healthcare (1051)
Name
電話
(925) 401-7300
Name
住所
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Name
職員
1,178
Name
Twitter
@10xgenomics
Name
次回の収益日
2026-11-05
Name
最新のSEC提出書
Name
TXG's Discussions on Twitter

Compare TXG vs ABT, MDT, SYK, BSX, EW

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
TXG icon
TXG
10 X Genomics Inc
75.19 9.80B 638.78M -22.66M 122.18M -0.1744
ABT icon
ABT
Abbott Laboratories
101.82 176.19B 46.59B 5.41B 7.38B 3.0938
MDT icon
MDT
Medtronic Plc
91.93 117.59B 36.36B 4.84B 5.43B 3.7261
SYK icon
SYK
Stryker Corp
282.60 108.40B 25.27B 3.34B 4.57B 8.6334
BSX icon
BSX
Boston Scientific Corp
43.84 63.53B 20.62B 3.56B 3.48B 2.3847
EW icon
EW
Edwards Lifesciences Corp
86.39 49.80B 6.30B 1.07B 1.09B 1.8406

10 X Genomics Inc Stock (TXG) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-09-28 開始されました Argus Buy
2026-09-09 再開されました UBS Neutral
2026-09-01 開始されました RBC Capital Mkts Sector Perform
2026-03-31 アップグレード William Blair Mkt Perform → Outperform
2025-12-11 ダウングレード Citigroup Buy → Neutral
2025-12-02 ダウングレード Morgan Stanley Overweight → Equal-Weight
2025-09-11 開始されました Piper Sandler Neutral
2025-02-13 ダウングレード Leerink Partners Outperform → Market Perform
2024-09-03 開始されました Leerink Partners Outperform
2024-07-22 アップグレード Jefferies Hold → Buy
2024-07-18 ダウングレード JP Morgan Overweight → Neutral
2024-07-10 ダウングレード Deutsche Bank Buy → Hold
2024-06-27 ダウングレード Wolfe Research Outperform → Peer Perform
2024-06-25 ダウングレード Guggenheim Buy → Neutral
2024-06-03 再開されました Jefferies Hold
2024-05-01 ダウングレード TD Cowen Buy → Hold
2023-12-14 開始されました Guggenheim Buy
2023-12-13 開始されました Wolfe Research Outperform
2023-12-12 アップグレード BofA Securities Underperform → Neutral
2023-07-05 再開されました JP Morgan Overweight
2023-05-10 開始されました Barclays Overweight
2023-03-31 開始されました Stephens Overweight
2023-02-02 開始されました UBS Neutral
2022-12-14 開始されました Deutsche Bank Buy
2022-08-18 ダウングレード Goldman Neutral → Sell
2022-07-25 開始されました Canaccord Genuity Buy
2022-07-15 ダウングレード BofA Securities Neutral → Underperform
2022-07-15 ダウングレード William Blair Outperform → Mkt Perform
2021-10-15 再開されました Cowen Outperform
2021-09-14 ダウングレード BofA Securities Buy → Neutral
2021-03-15 開始されました William Blair Outperform
2020-12-02 開始されました Goldman Neutral
2020-09-09 開始されました Morgan Stanley Overweight
2020-07-10 開始されました Stifel Buy
2020-03-05 開始されました Guggenheim Buy
2020-01-07 開始されました Citigroup Buy
2019-10-07 開始されました BofA/Merrill Buy
2019-10-07 開始されました Cowen Outperform
2019-10-07 開始されました JP Morgan Overweight
2019-09-24 開始されました Evercore ISI Outperform
すべてを表示

10 X Genomics Inc (TXG) 最新ニュース

pulisher
Oct 08, 2026

10x Genomics & Fred Hutch Join Forces on Cancer Biomarker Research - Zacks Investment Research

Oct 08, 2026
pulisher
Oct 07, 2026

ARK and Catherine D. Wood report ownership above 5% in 10x Genomics (TXG). - Stock Titan

Oct 07, 2026
pulisher
Oct 06, 2026

Global Microfluidics Market by Product Type, Application, End User, and Region, 2026-2036 | $48.04 Billion Opportunity Driven by Point-of-Care Diagnostics and Automation - GlobeNewswire Inc.

Oct 06, 2026
pulisher
Sep 30, 2026

10x Genomics Begins Atera Shipments as Spatial Biology Demand Rises - Zacks Investment Research

Sep 30, 2026
pulisher
Sep 24, 2026

10x genomics director Shehnaaz Suliman sells $464,667 in stock - Investing.com

Sep 24, 2026
pulisher
Sep 24, 2026

Form 4 10X Genomics Inc For: 24 September By Investing.com - Investing.com India

Sep 24, 2026
pulisher
Sep 24, 2026

10x genomics director Shehnaaz Suliman sells $464,667 in stock By Investing.com - Investing.com Canada

Sep 24, 2026
pulisher
Sep 24, 2026

Form 4 10X Genomics Inc For: 24 September By Investing.com - Investing.com UK

Sep 24, 2026
pulisher
Sep 24, 2026

Under a trading plan, a 10x Genomics (TXG) director sells 5,723 shares in five transactions. - Stock Titan

Sep 24, 2026
pulisher
Sep 24, 2026

At $77.75 to $82.53 a share, 10x Genomics (TXG) CEO made five sales under a trading plan. - Stock Titan

Sep 24, 2026
pulisher
Sep 22, 2026

5,723 10x Genomics (NASDAQ: TXG) shares set for Rule 144 sale - Stock Titan

Sep 22, 2026
pulisher
Sep 12, 2026

Korea's Lunit announces collaboration with 10x Genomics for AI-enabled pathology analysis of cancer - BioSpectrum Asia

Sep 12, 2026
pulisher
Sep 12, 2026

Moderna, 10x Genomics, Oscar Health, and Novavax Shares Are Soaring, What You Need To Know - Yahoo Finance

Sep 12, 2026
pulisher
Sep 11, 2026

10x Genomics (TXG) CFO Adam Taich Sells 46,388 Shares - GuruFocus

Sep 11, 2026
pulisher
Sep 11, 2026

10x genomics CFO Adam Taich disposes of $2.99 million in company stock - Investing.com Nigeria

Sep 11, 2026
pulisher
Sep 11, 2026

10x genomics CFO Adam Taich disposes of $2.99 million in company stock - Investing.com

Sep 11, 2026
pulisher
Sep 11, 2026

10x Genomics Inc (TXG) Shares Surge 3.3% -- What GF Score of 56 Tells Investors - GuruFocus

Sep 11, 2026
pulisher
Sep 11, 2026

10x genomics CFO Adam Taich disposes of $2.99 million in company stock - Investing.com

Sep 11, 2026
pulisher
Sep 11, 2026

10x Genomics (TXG) CFO sells shares under preset trading plan - Stock Titan

Sep 11, 2026
pulisher
Sep 11, 2026

Korea's Lunit announces collaboration with 10x Genomics for AI-enabled pathology analysis of cancer - BioSpectrum Asia

Sep 11, 2026
pulisher
Sep 11, 2026

Korea's Lunit announces collaboration with 10x Genomics for AI-enabled pathology analysis of cancer - BioSpectrum Asia

Sep 11, 2026
pulisher
Sep 11, 2026

10x Genomics CFO Adam Taich sells USD 2.99 million in common shares - Bitget

Sep 11, 2026
pulisher
Sep 11, 2026

10x genomics CFO Adam Taich disposes of $2.99 million in company stock - Investing.com UK

Sep 11, 2026
pulisher
Sep 11, 2026

10x Genomics Insider Sold Shares Worth $2,995,470, According to a Recent SEC Filing - Yahoo Finance

Sep 11, 2026
pulisher
Sep 10, 2026

10x Genomics to Use Lunit’s AI-Powered Pathology Platform for Oncology Biomarker Discovery - GenomeWeb

Sep 10, 2026
pulisher
Sep 10, 2026

AI will pair tissue scans with molecular maps in cancer studies - Stock Titan

Sep 10, 2026
pulisher
Sep 09, 2026

10x genomics director Stuelpnagel sells $1.2 million in shares By Investing.com - Investing.com Australia

Sep 09, 2026
pulisher
Sep 09, 2026

10x Genomics (NASDAQ: TXG) executive plans multimillion-dollar stock sale - Stock Titan

Sep 09, 2026
pulisher
Sep 09, 2026

10x Genomics Insider John R. Stuelpnagel Sells 20,000 Shares Between $60.66 and $62.61 on September 3, 2026 (NASDAQ: TXG) - kalkinemedia.com

Sep 09, 2026
pulisher
Sep 09, 2026

10x Genomics stock hits 52-week high at 66.95 USD By Investing.com - Investing.com South Africa

Sep 09, 2026
pulisher
Sep 09, 2026

10x Genomics Insider Sold Shares Worth $1,235,072, According to a Recent SEC Filing - Yahoo Finance

Sep 09, 2026
pulisher
Sep 09, 2026

Macrogen to offer 10x Genomics spatial biology platform in Asia first - Korea Biomedical Review

Sep 09, 2026
pulisher
Sep 08, 2026

10x genomics director Stuelpnagel sells $1.2 million in shares - Investing.com

Sep 08, 2026
pulisher
Sep 08, 2026

10x Genomics Inc (TXG) Stock Up 4.7% but GF Value Says Overvalued -- GF Score: 56/100 - GuruFocus

Sep 08, 2026
pulisher
Sep 08, 2026

10x Genomics (TXG) director offloads 20,000 shares in open-market trades - Stock Titan

Sep 08, 2026
pulisher
Sep 08, 2026

T. Rowe Price reports 10%+ holding in 10x Genomics (TXG) - Stock Titan

Sep 08, 2026
pulisher
Sep 08, 2026

Stifel reiterates Buy rating on 10X Genomics stock - investing.com

Sep 08, 2026
pulisher
Sep 04, 2026

10X Genomics Inc (TXG) Key Financial Ratios – Valuation, Profitability & More - Value Research

Sep 04, 2026
pulisher
Sep 03, 2026

10x Genomics (TXG) CEO holds 1,075,249 shares after 100-share gift - Stock Titan

Sep 03, 2026
pulisher
Sep 03, 2026

Founder trust at 10x Genomics (NASDAQ: TXG) moves to sell 20,000 shares - Stock Titan

Sep 03, 2026
pulisher
Sep 03, 2026

10x Genomics Rallies 84% in 3 Months: Is There More Upside Ahead? - finance.yahoo.com

Sep 03, 2026
pulisher
Sep 02, 2026

TXG Stock Price and Chart — NASDAQ:TXG - TradingView

Sep 02, 2026
pulisher
Sep 01, 2026

A Look at 10x Genomics Inc (TXG) After 4.0% Decline -- GF Value $18.36 vs Price $60.00 - GuruFocus

Sep 01, 2026
pulisher
Sep 01, 2026

RBC Capital initiates 10X Genomics stock with Sector Perform rating - investing.com

Sep 01, 2026
pulisher
Sep 01, 2026

10X GENOMICS, INC. : RBC INITIATES COVERAGE WITH SECTOR PERFORM RATING; TARGET PRICE $70 - Bitget

Sep 01, 2026
pulisher
Aug 31, 2026

10X GENOMICS, INC. : RBC INITIATES COVERAGE WITH SECTOR PERFORM RATING; TARGET PRICE $70 - Bitget

Aug 31, 2026
pulisher
Aug 31, 2026

Jury Awards 10x Genomics Millions in Patent Lawsuit Against Qiagen Unit - Benzinga

Aug 31, 2026
pulisher
Aug 31, 2026

TXG Stock Down Despite Patent Verdict Win Against Parse Biosciences - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

10X Genomics Inc (TXG) Peer Comparison – Compare with Others - Value Research

Aug 31, 2026
pulisher
Aug 31, 2026

10x Genomics Wins Patent Infringement Verdict against Parse Biosciences - marketscreener.com

Aug 31, 2026

10 X Genomics Inc (TXG) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

10 X Genomics Inc (TXG) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Saxonov Serge
Chief Executive Officer
Sep 22 '26
Sale
81.22
25,000
2,030,562
1,050,249
Shehnaaz Suliman
Affiliate
Sep 22 '26
Proposed Sale
79.10
5,723
452,689
0
Taich Adam
Chief Financial Officer
Sep 09 '26
Sale
64.57
46,388
2,995,470
316,344
ADAM TAICH
Officer
Sep 09 '26
Proposed Sale
64.57
46,388
2,995,470
0
STUELPNAGEL JOHN R
Director
Sep 03 '26
Sale
61.75
20,000
1,235,072
328,436
STUELPNAGEL JOHN R
Director
Sep 03 '26
Proposed Sale
61.75
20,000
1,235,046
0
Serge Saxonov
Director, CEO
Aug 26 '26
Proposed Sale
62.18
35,486
2,206,654
0
Saxonov Serge
Chief Executive Officer
Aug 26 '26
Sale
63.69
10,486
667,901
1,075,349
SULIMAN SHEHNAAZ
Director
Aug 24 '26
Sale
63.65
2,207
140,478
29,515
Taich Adam
Officer
Aug 24 '26
Proposed Sale
65.12
16,614
1,081,904
0
$365.08
price up icon 8.33%
BIO BIO
$364.42
price down icon 0.48%
$139.81
price up icon 3.35%
$168.02
price up icon 1.41%
$76.24
price up icon 2.13%
$56.25
price down icon 4.40%
大文字化:     |  ボリューム (24 時間):